2023 Q4 Form 10-Q Financial Statement

#000165495423014354 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $28.26M $25.73M
YoY Change 21.07% 1.83%
Cost Of Revenue $24.23M $21.84M
YoY Change 22.48% 1.71%
Gross Profit $4.031M $3.895M
YoY Change 13.25% 2.51%
Gross Profit Margin 14.27% 15.14%
Selling, General & Admin $4.801M $4.468M
YoY Change 19.09% 8.36%
% of Gross Profit 119.11% 114.71%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.051M $780.0K
YoY Change 37.71% 186.55%
% of Gross Profit 26.07% 20.03%
Operating Expenses $5.092M $4.728M
YoY Change 18.46% 7.56%
Operating Profit -$1.061M -$832.7K
YoY Change 43.58% 39.81%
Interest Expense -$3.180K -$40.00K
YoY Change -93.05% -163.65%
% of Operating Profit
Other Income/Expense, Net -$9.880K -$75.08K
YoY Change -102.6% 18.34%
Pretax Income -$1.267M -$907.8K
YoY Change 213.36% 37.74%
Income Tax $64.82K $13.31K
% Of Pretax Income
Net Earnings -$1.332M -$921.1K
YoY Change -85.02% 70.3%
Net Earnings / Revenue -4.71% -3.58%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.15 -$0.10
COMMON SHARES
Basic Shares Outstanding 8.844M shares 8.893M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.921M $8.500M
YoY Change -8.1% 67.94%
Cash & Equivalents $6.921M $8.458M
Short-Term Investments
Other Short-Term Assets $717.6K $1.403M
YoY Change -23.34% -52.09%
Inventory $366.1K $494.1K
Prepaid Expenses
Receivables $24.84M $8.912M
Other Receivables $0.00 $0.00
Total Short-Term Assets $32.84M $28.73M
YoY Change 17.35% 0.55%
LONG-TERM ASSETS
Property, Plant & Equipment $4.826M $857.9K
YoY Change 393.35% -19.27%
Goodwill $5.812M $5.812M
YoY Change 0.0% 0.0%
Intangibles $7.336M $7.134M
YoY Change -0.84% 7.47%
Long-Term Investments
YoY Change
Other Assets $483.3K $1.557M
YoY Change -76.14% -46.9%
Total Long-Term Assets $18.46M $19.66M
YoY Change -12.21% -33.63%
TOTAL ASSETS
Total Short-Term Assets $32.84M $28.73M
Total Long-Term Assets $18.46M $19.66M
Total Assets $51.30M $48.39M
YoY Change 4.67% -16.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.63M $13.86M
YoY Change 0.95% -8.26%
Accrued Expenses $16.81M $10.62M
YoY Change 48.44% 24.29%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $31.46M $27.32M
YoY Change 20.32% 4.14%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $5.149M $5.500M
YoY Change 0.62% -2.1%
Total Long-Term Liabilities $5.149M $5.500M
YoY Change 0.62% -2.1%
TOTAL LIABILITIES
Total Short-Term Liabilities $31.46M $27.32M
Total Long-Term Liabilities $5.149M $5.500M
Total Liabilities $36.62M $32.83M
YoY Change 17.15% 3.08%
SHAREHOLDERS EQUITY
Retained Earnings -$87.15M -$85.82M
YoY Change 4.87% 15.64%
Common Stock $102.2M $8.894K
YoY Change 0.95% 1.93%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $14.68M $15.56M
YoY Change
Total Liabilities & Shareholders Equity $51.30M $48.39M
YoY Change 4.67% -16.85%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$1.332M -$921.1K
YoY Change -85.02% 70.3%
Depreciation, Depletion And Amortization $1.051M $780.0K
YoY Change 37.71% 186.55%
Cash From Operating Activities -$1.215M $820.0K
YoY Change -142.61% -185.2%
INVESTING ACTIVITIES
Capital Expenditures $110.1K $260.0K
YoY Change -68.14% -128.5%
Acquisitions
YoY Change
Other Investing Activities -$900.00 $330.0K
YoY Change
Cash From Investing Activities -$111.0K $60.00K
YoY Change -67.88% -106.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -170.1K -160.0K
YoY Change 10.67% 6.98%
NET CHANGE
Cash From Operating Activities -1.215M 820.0K
Cash From Investing Activities -111.0K 60.00K
Cash From Financing Activities -170.1K -160.0K
Net Change In Cash -1.496M 720.0K
YoY Change -163.61% -135.57%
FREE CASH FLOW
Cash From Operating Activities -$1.215M $820.0K
Capital Expenditures $110.1K $260.0K
Free Cash Flow -$1.325M $560.0K
YoY Change -152.88% -1216.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
535417 usd
CY2022Q2 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
1100000 usd
us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
2900000 usd
us-gaap Revenues
Revenues
70765353 usd
CY2022Q1 wyy Carrier Service Costs
CarrierServiceCosts
8402770 usd
CY2023Q3 wyy Contingent Consideration Warrants
ContingentConsiderationWarrants
400 usd
CY2022Q4 wyy Contingent Consideration Warrants
ContingentConsiderationWarrants
400 usd
CY2023Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
6900 usd
CY2022Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
6900 usd
CY2023Q3 us-gaap Accounts Receivable Gross
AccountsReceivableGross
8984273 usd
CY2022Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
9328775 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
72398 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
51666 usd
CY2023Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
8911875 usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
9277109 usd
CY2023Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1665088 usd
CY2022Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1637628 usd
CY2023Q3 us-gaap Other Inventory Purchased Goods
OtherInventoryPurchasedGoods
1004362 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
222279 usd
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
11327269 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4067664 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3360606 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3089446 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
857867 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
978218 usd
CY2023Q3 wyy Property And Equipment Depreciation Expense
PropertyAndEquipmentDepreciationExpense
91900 usd
wyy Property And Equipment Depreciation Expense
PropertyAndEquipmentDepreciationExpense
281900 usd
CY2022Q3 wyy Property And Equipment Depreciation Expense
PropertyAndEquipmentDepreciationExpense
102000 usd
wyy Property And Equipment Depreciation Expense
PropertyAndEquipmentDepreciationExpense
305100 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
13279991 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6146146 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7133845 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2123820 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1450258 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
727570 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001034760
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2045714 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8725476 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8893220 shares
CY2022Q4 wyy Common Stock Par Value
CommonStockParValue
0.001
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0 pure
us-gaap Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Dividend Rate
ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0 pure
CY2022Q3 us-gaap Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Dividend Rate
ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate
0 pure
CY2022Q3 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
0 usd
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
0 usd
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
288570 shares
us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
153903 shares
us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
628572 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33035
dei Entity Registrant Name
EntityRegistrantName
WidePoint Corporation
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-2040275
dei Entity Address Address Line1
EntityAddressAddressLine1
11250 Waples Mill Road
dei Entity Address Address Line2
EntityAddressAddressLine2
South Tower 210
dei Entity Address City Or Town
EntityAddressCityOrTown
Fairfax
dei Entity Address State Or Province
EntityAddressStateOrProvince
VA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
22030
dei City Area Code
CityAreaCode
703
dei Local Phone Number
LocalPhoneNumber
349-2577
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
WYY
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8843673 shares
CY2023Q3 us-gaap Revenues
Revenues
25733657 usd
CY2022Q3 us-gaap Revenues
Revenues
25271572 usd
us-gaap Revenues
Revenues
77770195 usd
us-gaap Revenues
Revenues
70765353 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
528298 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
366885 usd
us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
1538883 usd
us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
961341 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
21838836 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
21472120 usd
us-gaap Cost Of Revenue
CostOfRevenue
66155797 usd
us-gaap Cost Of Revenue
CostOfRevenue
59749532 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
3894821 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
3799452 usd
us-gaap Gross Profit
GrossProfit
11614398 usd
us-gaap Gross Profit
GrossProfit
11015821 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
490037 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
527726 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1553887 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1665518 usd
CY2023Q3 wyy Share Based Compensation Expenses
ShareBasedCompensationExpenses
276570 usd
CY2022Q3 wyy Share Based Compensation Expenses
ShareBasedCompensationExpenses
115141 usd
wyy Share Based Compensation Expenses
ShareBasedCompensationExpenses
235570 usd
wyy Share Based Compensation Expenses
ShareBasedCompensationExpenses
269126 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3977709 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3595145 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11719042 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11157690 usd
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
16277000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
259804 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
272203 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
789331 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
810652 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
4727550 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
4395074 usd
us-gaap Operating Expenses
OperatingExpenses
14062260 usd
us-gaap Operating Expenses
OperatingExpenses
29910860 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-832729 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-595622 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2447862 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-18895039 usd
CY2023Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
27681 usd
CY2022Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
6398 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
39122 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
17126 usd
CY2023Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
69095 usd
CY2022Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
62841 usd
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
184783 usd
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
189188 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-33663 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6999 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-52721 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
964004 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-75077 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-63442 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-198382 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
791942 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-907806 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-659064 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2646244 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18103097 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13308 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-118181 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
68422 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3410108 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-921114 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-540883 usd
us-gaap Net Income Loss
NetIncomeLoss
-14692989 usd
CY2023Q3 wyy Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.10
CY2022Q3 wyy Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.06
wyy Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.31
wyy Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-1.68
CY2023Q3 wyy Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
8893220 shares
CY2022Q3 wyy Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
8725476 shares
wyy Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
8809644 shares
wyy Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
8734471 shares
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-921114 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-540883 usd
us-gaap Net Income Loss
NetIncomeLoss
-2714666 usd
us-gaap Net Income Loss
NetIncomeLoss
-14692989 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-77162 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-118524 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-7510 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-258213 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-77162 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-118524 usd
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-7510 usd
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-258213 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-998276 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-659407 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2722176 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14951202 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8458048 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7530864 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
72398 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
51666 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8911875 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9277109 usd
CY2023Q3 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
9956194 usd
CY2022Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
10244101 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1402845 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
935978 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
28728962 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
27988052 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
857867 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
978218 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4215558 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4723899 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7133845 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7398160 usd
CY2023Q3 us-gaap Goodwill
Goodwill
5811578 usd
CY2022Q4 us-gaap Goodwill
Goodwill
5811578 usd
CY2023Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
85888 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
86909 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1556995 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2025845 usd
CY2023Q3 us-gaap Assets
Assets
48390693 usd
CY2022Q4 us-gaap Assets
Assets
49012661 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
13855297 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
12515081 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10624832 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11327269 usd
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2209524 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1704933 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
626955 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
596529 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
27316608 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
26143812 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4298076 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4745909 usd
CY2023Q3 wyy Contingent Consideration
ContingentConsideration
6900 usd
CY2022Q4 wyy Contingent Consideration
ContingentConsideration
6900 usd
CY2023Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1208293 usd
CY2022Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
364837 usd
CY2023Q3 us-gaap Liabilities
Liabilities
32829877 usd
CY2022Q4 us-gaap Liabilities
Liabilities
31261458 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2045714 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8893220 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8725476 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
8894 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
8726 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
101725806 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
101194185 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-357744 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-350234 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-85816140 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-83101474 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
15560816 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
17751203 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
48390693 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
49012661 usd
us-gaap Profit Loss
ProfitLoss
2714666 usd
us-gaap Profit Loss
ProfitLoss
14692989 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3176568 usd
us-gaap Depreciation
Depreciation
794344 usd
us-gaap Depreciation
Depreciation
813624 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
16277000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
39979 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
244 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1533870 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
958369 usd
us-gaap Share Based Compensation
ShareBasedCompensation
535417 usd
us-gaap Share Based Compensation
ShareBasedCompensation
384267 usd
wyy Warrants Expense
WarrantsExpense
0 usd
wyy Warrants Expense
WarrantsExpense
108000 usd
wyy Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
0 usd
wyy Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
960000 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-3211 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1208899 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2804675 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
271869 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-47618 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
198992 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-209399 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-27161 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-27966 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-504739 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1080368 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
29780 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
7600 usd
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
1352781 usd
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-314226 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
0 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-358000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1835176 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3217347 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
166210 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
239233 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
810219 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
2823887 usd
us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
469104 usd
us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-507325 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3063120 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
6493284 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
4455523 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
6493284 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
4455523 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
420139 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
446691 usd
wyy Withholding Taxes Paid On Behalf Of Employees On Net Settled Restricted Stock Awards
WithholdingTaxesPaidOnBehalfOfEmployeesOnNetSettledRestrictedStockAwards
-3628 usd
wyy Withholding Taxes Paid On Behalf Of Employees On Net Settled Restricted Stock Awards
WithholdingTaxesPaidOnBehalfOfEmployeesOnNetSettledRestrictedStockAwards
-49224 usd
wyy Common Stock Repurchased
CommonStockRepurchased
0 usd
wyy Common Stock Repurchased
CommonStockRepurchased
-818211 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-423767 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1314126 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23100 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-258761 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
927184 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1418660 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7530864 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6479980 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8458048 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5061320 usd
us-gaap Interest Paid Net
InterestPaidNet
168083 usd
us-gaap Interest Paid Net
InterestPaidNet
141924 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
27559 usd
wyy Capitalized Hardware And Software Development Costs In Accounts Payable
CapitalizedHardwareAndSoftwareDevelopmentCostsInAccountsPayable
22198 usd
wyy Capitalized Hardware And Software Development Costs In Accounts Payable
CapitalizedHardwareAndSoftwareDevelopmentCostsInAccountsPayable
90854 usd
wyy Leased Assets And Lease Liabilities Terminated
LeasedAssetsAndLeaseLiabilitiesTerminated
0 usd
wyy Leased Assets And Lease Liabilities Terminated
LeasedAssetsAndLeaseLiabilitiesTerminated
876281 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
41675995 usd
CY2022Q1 wyy Common Stock Repurchased Amount
CommonStockRepurchasedAmount
-818211 usd
CY2022Q1 wyy Issuance Of Common Stock Restricted Amount
IssuanceOfCommonStockRestrictedAmount
-49224 usd
CY2022Q1 wyy Issuance Of Warrants In Acquisition Of It Authorities Inc
IssuanceOfWarrantsInAcquisitionOfItAuthoritiesInc
108000 usd
CY2022Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
179741 usd
CY2022Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-4835 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-392897 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
40698569 usd
CY2022Q2 wyy Stock Compensation Expense Restricted
StockCompensationExpenseRestricted
89385 usd
CY2022Q2 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-134854 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-13759209 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
26893891 usd
CY2022Q3 wyy Stock Compensation Expense Restricted
StockCompensationExpenseRestricted
115141 usd
CY2022Q3 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-118524 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-540883 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
26349625 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
17751203 usd
CY2023Q1 wyy Issuance Of Common Stock Restricted Amount
IssuanceOfCommonStockRestrictedAmount
-3628 usd
CY2023Q1 wyy Stock Compensation Expense Restricted
StockCompensationExpenseRestricted
140116 usd
CY2023Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
37248 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-951479 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
16973460 usd
CY2023Q2 wyy Stock Compensation Expense Restricted
StockCompensationExpenseRestricted
95454 usd
CY2023Q2 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
32404 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-842073 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
16259245 usd
CY2023Q3 wyy Stock Compensation Expense Restricted
StockCompensationExpenseRestricted
276570 usd
CY2023Q3 wyy Stock Compensation Expense Non Qualified Stock Options
StockCompensationExpenseNonQualifiedStockOptions
23277 usd
CY2023Q3 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-77162 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-921114 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
15560816 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The more significant areas requiring use of estimates and judgment relate to revenue recognition, allowance for credit losses, ability to realize intangible assets and goodwill, ability to realize deferred income tax assets, fair value of certain financial instruments and the evaluation of contingencies and litigation. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results could differ from those estimates. There were no significant changes in accounting estimates used by management during the quarter.</p>
wyy Significant Accounting Policies
SignificantAccountingPolicies
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">There were no significant changes in the Company’s significant accounting policies during the first nine months of 2023 from those disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC on March 31, 2023.</p>
CY2022Q4 wyy Contingent Consideration Cash Settled
ContingentConsiderationCashSettled
6500 usd
CY2023Q3 wyy Contingent Consideration Cash Settled
ContingentConsiderationCashSettled
6500 usd
CY2022Q4 wyy Contingent Consideration Cash Settled
ContingentConsiderationCashSettled
6500 usd
CY2023Q3 wyy Contingent Consideration Warrants
ContingentConsiderationWarrants
400 usd
CY2022Q4 wyy Contingent Consideration Warrants
ContingentConsiderationWarrants
400 usd
CY2023Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
6900 usd
CY2022Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
6900 usd
wyy Schedule Of Accounts Receivable By Customer Tabletextblock
ScheduleOfAccountsReceivableByCustomerTabletextblock
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SEPTEMBER 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">DECEMBER 31,</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-TOP: medium none; BORDER-BOTTOM: 0.5pt solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-TOP: medium none; BORDER-BOTTOM: 0.5pt solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">2022</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>As a % of</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">As a % of</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-TOP: medium none; BORDER-BOTTOM: 0.5pt solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Customer Type</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-TOP: medium none; BORDER-BOTTOM: 0.5pt solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Receivables</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-TOP: medium none; BORDER-BOTTOM: 0.5pt solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Receivables</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Unaudited)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">U.S. Federal Government</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>73</strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>%</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">78</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr></tbody></table>
CY2023Q3 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
7100000 usd
CY2023Q3 us-gaap Deposits Foreign
DepositsForeign
560000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
494101 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
908744 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
713699 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1402845 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
935978 usd
CY2023Q3 wyy Carrier Service Costs
CarrierServiceCosts
7845150 usd
CY2022Q1 us-gaap Other Inventory Purchased Goods
OtherInventoryPurchasedGoods
1205209 usd
CY2023Q3 wyy Other Severance Costs
OtherSeveranceCosts
7612 usd
CY2022Q1 wyy Other Severance Costs
OtherSeveranceCosts
7612 usd
CY2023Q3 wyy Other Us Income Tax Payable Assets
OtherUSIncomeTaxPayableAssets
46720 usd
CY2022Q1 wyy Other Us Income Tax Payable Assets
OtherUSIncomeTaxPayableAssets
61490 usd
CY2023Q3 wyy Other Foreign Income Tax Payable Assets
OtherForeignIncomeTaxPayableAssets
55900 usd
CY2022Q1 wyy Other Foreign Income Tax Payable Assets
OtherForeignIncomeTaxPayableAssets
12560 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
10624832 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4218473 usd
CY2023Q3 us-gaap Goodwill
Goodwill
5811578 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
12016509 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-4618349 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7398160 usd
CY2023Q3 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
139600 usd
us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
832400 usd
CY2023Q3 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
526300 usd
CY2022Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
365800 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
1533900 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
958400 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
566031 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
503106 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
1763060 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7133845 usd
wyy Net Paid Percentage
NetPaidPercentage
0.90 pure
CY2023Q3 wyy Receivable Sold
ReceivableSold
36000 usd
wyy Receivable Sold
ReceivableSold
52000 usd
CY2023Q3 us-gaap Proceeds From Fees Received
ProceedsFromFeesReceived
35000 usd
us-gaap Proceeds From Fees Received
ProceedsFromFeesReceived
51000 usd
CY2023Q3 wyy Outstanding Payment Balance
OutstandingPaymentBalance
4000000 usd
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.015 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.026 pure
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.18 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.19 pure
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2023Q3 wyy Common Stock Par Value
CommonStockParValue
0.001
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8893220 shares
CY2023Q3 wyy Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
5.33
CY2019Q4 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
250000 shares
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
299847 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
115141 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
384267 usd
CY2023Q3 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
628572 shares
CY2022Q3 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
153903 shares
CY2023Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
288570 shares
wyy Warrantsto Purchasec Cmmon Shares Outstanding
WarrantstoPurchasecCmmonSharesOutstanding
150000 shares
wyy Warrantsto Purchasec Cmmon Shares Outstanding
WarrantstoPurchasecCmmonSharesOutstanding
150000 shares
wyy Scheduleofoption Pricing Model Tabletextblock
ScheduleofoptionPricingModelTabletextblock
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>THREE MONTHS ENDED</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>NINE MONTHS ENDED</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>SEPTEMBER 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>SEPTEMBER 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">2022</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">2022</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Stock options granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>288,570</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>--</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>288,570</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>--</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Expected dividend yield</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>0</strong><strong>%</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>--</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>0</strong><strong>%</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>--</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Expected volatility</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>61.6%-62.2</strong><strong>%</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>--</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>61.6%-62.2%</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>--</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Risk-free interest rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>4.1</strong><strong>%</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>--</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>4.1</strong><strong>%</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>--</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Term</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>4 years</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>--</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>4years</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>--</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2023Q3 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
288570 usd
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
288570 usd
CY2023Q3 us-gaap Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Dividend Rate
ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate
0 pure
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.041 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.041 pure
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y
CY2023Q3 wyy Unrecognized Share Based Expense
UnrecognizedShareBasedExpense
1200000 usd
us-gaap Insured Financial Obligations With Credit Deterioration Remaining Weighted Average Contract Period
InsuredFinancialObligationsWithCreditDeteriorationRemainingWeightedAverageContractPeriod
P1Y
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-921114 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-540883 usd
us-gaap Net Income Loss
NetIncomeLoss
-2714666 usd
us-gaap Net Income Loss
NetIncomeLoss
-14692989 usd
CY2023Q3 wyy Weighted Average Number Of Common Shares Basic And Diluted
WeightedAverageNumberOfCommonSharesBasicAndDiluted
8893220 shares
CY2022Q3 wyy Weighted Average Number Of Common Shares Basic And Diluted
WeightedAverageNumberOfCommonSharesBasicAndDiluted
8725476 shares
wyy Weighted Average Number Of Common Shares Basic And Diluted
WeightedAverageNumberOfCommonSharesBasicAndDiluted
8809644 shares
wyy Weighted Average Number Of Common Shares Basic And Diluted
WeightedAverageNumberOfCommonSharesBasicAndDiluted
8734471 shares
CY2023Q3 wyy Basic And Diluted Loss Per Shares
BasicAndDilutedLossPerShares
-0.10
CY2022Q3 wyy Basic And Diluted Loss Per Shares
BasicAndDilutedLossPerShares
-0.06
wyy Basic And Diluted Loss Per Shares
BasicAndDilutedLossPerShares
-0.31
wyy Basic And Diluted Loss Per Shares
BasicAndDilutedLossPerShares
-1.68
CY2023Q2 us-gaap Stock Or Units Available For Distributions
StockOrUnitsAvailableForDistributions
55117 shares
CY2022Q2 us-gaap Stock Or Units Available For Distributions
StockOrUnitsAvailableForDistributions
43058 shares
CY2023Q2 wyy Warrantsto Purchasec Cmmon Shares Outstanding
WarrantstoPurchasecCmmonSharesOutstanding
150000 shares
CY2022Q2 wyy Warrantsto Purchasec Cmmon Shares Outstanding
WarrantstoPurchasecCmmonSharesOutstanding
150000 shares
us-gaap Stock Or Units Available For Distributions
StockOrUnitsAvailableForDistributions
43103 shares
us-gaap Stock Or Units Available For Distributions
StockOrUnitsAvailableForDistributions
64012 shares
CY2023Q3 us-gaap Revenues
Revenues
25733657 usd
CY2022Q3 us-gaap Revenues
Revenues
25271572 usd
us-gaap Revenues
Revenues
77770195 usd
us-gaap Revenues
Revenues
70765353 usd
CY2023Q3 us-gaap Revenues
Revenues
25733657 usd
CY2022Q3 us-gaap Revenues
Revenues
25271572 usd
us-gaap Revenues
Revenues
77770195 usd
CY2023Q3 us-gaap Revenues
Revenues
25733657 usd
CY2022Q3 us-gaap Revenues
Revenues
25271572 usd
us-gaap Revenues
Revenues
77770195 usd
us-gaap Revenues
Revenues
70765353 usd
CY2023Q3 wyy Revenue Related Approximately
RevenueRelatedApproximately
352100 usd
CY2022Q3 wyy Revenue Related Approximately
RevenueRelatedApproximately
485400 usd
wyy Revenue Related Approximately
RevenueRelatedApproximately
1600000 usd
wyy Revenue Related Approximately
RevenueRelatedApproximately
2100000 usd

Files In Submission

Name View Source Status
0001654954-23-014354-index-headers.html Edgar Link pending
0001654954-23-014354-index.html Edgar Link pending
0001654954-23-014354.txt Edgar Link pending
0001654954-23-014354-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wyy-20230930.xsd Edgar Link pending
wyy_10q.htm Edgar Link pending
wyy_ex101.htm Edgar Link pending
wyy_ex101img29.jpg Edgar Link pending
wyy_ex101img30.jpg Edgar Link pending
wyy_ex101img31.jpg Edgar Link pending
wyy_ex101img32.jpg Edgar Link pending
wyy_ex101img33.jpg Edgar Link pending
wyy_ex101img34.jpg Edgar Link pending
wyy_ex101img35.jpg Edgar Link pending
wyy_ex101img36.jpg Edgar Link pending
wyy_ex101img37.jpg Edgar Link pending
wyy_ex101img38.jpg Edgar Link pending
wyy_ex101img39.jpg Edgar Link pending
wyy_ex101img40.jpg Edgar Link pending
wyy_ex101img41.jpg Edgar Link pending
wyy_ex101img42.jpg Edgar Link pending
wyy_ex311.htm Edgar Link pending
wyy_ex312.htm Edgar Link pending
wyy_ex32.htm Edgar Link pending
wyy-20230930_lab.xml Edgar Link unprocessable
wyy-20230930_def.xml Edgar Link unprocessable
wyy-20230930_cal.xml Edgar Link unprocessable
wyy-20230930_pre.xml Edgar Link unprocessable
wyy_10q_htm.xml Edgar Link completed